IL92103A0 - 3beta,17beta-hydroxy-substituted steroids,related steroidal compounds and pharmaceutical compositions containing them - Google Patents

3beta,17beta-hydroxy-substituted steroids,related steroidal compounds and pharmaceutical compositions containing them

Info

Publication number
IL92103A0
IL92103A0 IL92103A IL9210389A IL92103A0 IL 92103 A0 IL92103 A0 IL 92103A0 IL 92103 A IL92103 A IL 92103A IL 9210389 A IL9210389 A IL 9210389A IL 92103 A0 IL92103 A0 IL 92103A0
Authority
IL
Israel
Prior art keywords
compounds
hydroxy
17beta
3beta
pharmaceutical compositions
Prior art date
Application number
IL92103A
Other languages
English (en)
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of IL92103A0 publication Critical patent/IL92103A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0025—Esters

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Silicon Polymers (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL92103A 1988-10-27 1989-10-24 3beta,17beta-hydroxy-substituted steroids,related steroidal compounds and pharmaceutical compositions containing them IL92103A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/263,091 US4882322A (en) 1988-10-27 1988-10-27 3β,17β-hydroxy-substituted steroids and related steroidal compounds

Publications (1)

Publication Number Publication Date
IL92103A0 true IL92103A0 (en) 1990-07-12

Family

ID=23000340

Family Applications (1)

Application Number Title Priority Date Filing Date
IL92103A IL92103A0 (en) 1988-10-27 1989-10-24 3beta,17beta-hydroxy-substituted steroids,related steroidal compounds and pharmaceutical compositions containing them

Country Status (18)

Country Link
US (1) US4882322A (fr)
EP (1) EP0366144B1 (fr)
JP (1) JP2750621B2 (fr)
KR (1) KR900006360A (fr)
CN (1) CN1042363A (fr)
AT (1) ATE111478T1 (fr)
AU (1) AU619608B2 (fr)
CA (1) CA2001264C (fr)
DE (1) DE68918219T2 (fr)
DK (1) DK533189A (fr)
ES (1) ES2063801T3 (fr)
FI (1) FI895084A7 (fr)
HU (1) HU204065B (fr)
IL (1) IL92103A0 (fr)
NO (1) NO173097C (fr)
NZ (1) NZ231107A (fr)
PT (1) PT92113B (fr)
ZA (1) ZA898025B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166201A (en) * 1990-11-30 1992-11-24 Merrell Dow Pharmaceuticals Inc. 2β,19-ethylene bridged steroids as aromatase inhibitors
AU4093799A (en) 1998-05-22 1999-12-13 Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
WO2005097141A2 (fr) * 2003-11-24 2005-10-20 Merck & Co., Inc. Modulateurs des recepteurs d'oestrogenes
WO2005051972A1 (fr) * 2003-11-24 2005-06-09 Merck & Co., Inc. Modulateurs des recepteurs estrogeniques
CA2789262C (fr) 2005-04-28 2016-10-04 Proteus Digital Health, Inc. Systeme pharma-informatique
EP1945240B1 (fr) 2005-09-16 2016-12-28 Raptor Pharmaceutical Inc Compositions de proteines rap specifiques des proteines contenant du cr, et leurs utilisations
TR201908314T4 (tr) 2009-02-20 2019-06-21 2 Bbb Medicines B V Glutatyon bazlı ilaç dağıtım sistemi.
KR101909711B1 (ko) 2009-05-06 2018-12-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
CN103555806B (zh) * 2013-11-16 2015-05-13 江南大学 一种高效利用亚麻刺盘孢霉合成7α-羟基-雄甾烯酮的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4322416A (en) * 1980-06-27 1982-03-30 Merrell Dow Pharmaceuticals Inc. 10-Alkynyl steroids
GB8531747D0 (en) * 1985-12-24 1986-02-05 Erba Farmitalia 10beta-alkynylestrene derivatives

Also Published As

Publication number Publication date
DE68918219D1 (de) 1994-10-20
ES2063801T3 (es) 1995-01-16
PT92113B (pt) 1995-06-30
HU204065B (en) 1991-11-28
AU619608B2 (en) 1992-01-30
NO894276D0 (no) 1989-10-26
JPH02174793A (ja) 1990-07-06
FI895084A7 (fi) 1990-04-28
JP2750621B2 (ja) 1998-05-13
HUT52113A (en) 1990-06-28
DK533189D0 (da) 1989-10-26
KR900006360A (ko) 1990-05-08
NO173097C (no) 1993-10-27
PT92113A (pt) 1990-04-30
NO894276L (no) 1990-04-30
ATE111478T1 (de) 1994-09-15
US4882322A (en) 1989-11-21
EP0366144A1 (fr) 1990-05-02
CN1042363A (zh) 1990-05-23
ZA898025B (en) 1990-07-25
HU895457D0 (en) 1990-01-28
FI895084A0 (fi) 1989-10-26
DE68918219T2 (de) 1995-02-02
EP0366144B1 (fr) 1994-09-14
AU4367989A (en) 1990-05-31
NO173097B (no) 1993-07-19
NZ231107A (en) 1992-03-26
CA2001264C (fr) 2001-05-01
CA2001264A1 (fr) 1990-04-27
DK533189A (da) 1990-04-28

Similar Documents

Publication Publication Date Title
ZA899671B (en) Phosphinic acid substituted steroids as inhibitors of steroid 5-alpha-reductase
ZA88549B (en) Steroid 5-alpha-reductase inhibitors
DE3570038D1 (en) Steroids for use as immunomodulators
IL92103A0 (en) 3beta,17beta-hydroxy-substituted steroids,related steroidal compounds and pharmaceutical compositions containing them
IL175398A0 (en) Steroidal compounds and pharmaceutical compositions containing them for treating oxidative stress and inflammation
GR3032257T3 (en) 17-Spiromethylene steroids
ZA899670B (en) Phosphonic acid substituted steroids as steroid 5-alpha-reductase inhibitors
DE3560902D1 (en) Vitamin d3 derivatives
IL88396A (en) Preparation of 6-methylene derivatives of androsta-1,4- diene-3,17-diones and pharmaceutical compositions containing them
DE3760277D1 (en) New 6- or 7-methylenandrosta-1, 4-diene-3,17-dione derivatives and process for their preparation
AP9300589A0 (en) Novel 17a and 17b substituted acyl-3-carboxy 3,5-diene steroidal compounds, pharmaceutical compositions containing these compounds, and methods for using these compounds to inhibit steroid 5-a-reductase.
ES2083254T3 (es) Composiciones para la administracion topica de espironolactona.
HUT51288A (en) Process for production of derivatives of 19-substituated progesteron and medical compositions containing them
GB2188932B (en) Steroidal compounds and process for lengthening the side-chain of certain steroids
BG102716A (en) Method for the treatment of cardiac insufficiency by means of formulations opposing the endotheline
DE3563971D1 (en) 1-alpha, 2-alpha-methylene-6-methylene and 6-alpha-methyl pregnenes, process for their preparation and pharmaceutical compositions containing them
HU9202100D0 (en) New 16-methyl-pregna-1,4-diene-3,20-dione derivatives
EP0559706A4 (fr)
MX9303970A (es) COMPUESTOS ESTEROIDALES DE ANILLO A DE 17Ó Y 17ß-ALQUILCETONA-3-CARBOXIAROMATICO.
HU913739D0 (en) Process for the production of 2 betha, 19-ethylene-bridge containing steroid aromatase inhibitors
WO1990015067A3 (fr) NOUVEAUX PROCEDES D'OBTENTION DE 6-METHYL 19-NOR STEROIDES ET LEUR CONVERSION EN 19-NOR PREGNADIENES 17α-SUBSTITUES
RU95113491A (ru) Новые стероиды, способ лечения, фармацевтическая композиция, способы получения

Legal Events

Date Code Title Description
HC Change of name of proprietor(s)

Owner name: AVENTIS INC.

Free format text: FORMER NAME:MERRELL PHARMACEUTICALS INC.